Safety and Efficacy of PTH 1‐34 and 1‐84 Therapy in Chronic Hypoparathyroidism: A Meta‐Analysis of Prospective Trials

Hypoparathyroidism is the only endocrine deficiency for which hormone replacement therapy is not the standard of care. Although conventional treatments may control hypocalcaemia, other complications such as hyperphosphatemia, kidney stones, peripheral calcifications, and bone disease remain unmet ne...

Descripción completa

Detalles Bibliográficos
Autores principales: Puliani, Giulia, Hasenmajer, Valeria, Simonelli, Ilaria, Sada, Valentina, Pofi, Riccardo, Minnetti, Marianna, Cozzolino, Alessia, Napoli, Nicola, Pasqualetti, Patrizio, Gianfrilli, Daniele, Isidori, Andrea M.
Formato: Online Artículo Texto
Lenguaje:English
Publicado: John Wiley & Sons, Inc. 2022
Materias:
Original Articles
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9545848/
https://www.ncbi.nlm.nih.gov/pubmed/35485213
http://dx.doi.org/10.1002/jbmr.4566

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9545848/
https://www.ncbi.nlm.nih.gov/pubmed/35485213
http://dx.doi.org/10.1002/jbmr.4566

Ejemplares similares